Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 variant B.1.617 is resistant to Bamlanivimab and evades antibodies induced by infection and vaccination
Markus Hoffmann, Heike Hofmann-Winkler, Nadine Krüger, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 90

Showing 26-50 of 90 citing articles:

The ins and outs of SARS-CoV-2 variants of concern (VOCs)
Mostafa Salehi‐Vaziri, Mehdi Fazlalipour, Seyed Mahmood Seyed Khorrami, et al.
Archives of Virology (2022) Vol. 167, Iss. 2, pp. 327-344
Open Access | Times Cited: 50
Pregnancy Outcomes and Maternal Complications During the Second Wave of Coronavirus Disease 2019 (COVID-19) in India
Niraj N. Mahajan, Madhura Pophalkar, Sarika Patil, et al.
Obstetrics and Gynecology (2021)
Open Access | Times Cited: 54
Model-driven mitigation measures for reopening schools during the COVID-19 pandemic
Ryan Seamus McGee, Julian R. Homburger, Hannah Williams, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 39
Open Access | Times Cited: 49
Resurgence of SARS-CoV-2 in India: Potential role of the B.1.617.2 (Delta) variant and delayed interventions
Maxwell Salvatore, Rupam Bhattacharyya, Soumik Purkayastha, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 47
SARS-CoV-2 B.1.617 emergence and sensitivity to vaccine-elicited antibodies
Petra Mlčochová, Steven A. Kemp, Mahesh Shanker Dhar, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 46
Interactions of the Receptor Binding Domain of SARS-CoV-2 Variants with hACE2: Insights from Molecular Docking Analysis and Molecular Dynamic Simulation
İsmail Çeli̇k, Rohitash Yadav, Zekeriya Düzgün, et al.
Biology (2021) Vol. 10, Iss. 9, pp. 880-880
Open Access | Times Cited: 46
Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity
Rüdiger Groß, Michelle Zanoni, Alina Seidel, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 45
Keep out! SARS-CoV-2 entry inhibitors: their role and utility as COVID-19 therapeutics
Lennox Chitsike, Penelope J. Duerksen-Hughes
Virology Journal (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 42
The Delta variant mutations in the receptor binding domain of SARS-CoV-2 show enhanced electrostatic interactions with the ACE2
Shaimaa S. Goher, Fedaa Ali, Muhamed Amin
Medicine in Drug Discovery (2021) Vol. 13, pp. 100114-100114
Open Access | Times Cited: 42
In Silico Analyses on the Comparative Potential of Therapeutic Human Monoclonal Antibodies Against Newly Emerged SARS-CoV-2 Variants Bearing Mutant Spike Protein
Nabarun Chandra Das, Pritha Chakraborty, Jagadeesh Bayry, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 36
SARS-CoV-2 Variants: A Synopsis of In Vitro Efficacy Data of Convalescent Plasma, Currently Marketed Vaccines, and Monoclonal Antibodies
Daniele Focosi, Marco Tuccori, Andreina Baj, et al.
Viruses (2021) Vol. 13, Iss. 7, pp. 1211-1211
Open Access | Times Cited: 40
High throughput sequencing based direct detection of SARS-CoV-2 fragments in wastewater of Pune, West India
Tanmay Dharmadhikari, Vinay Rajput, Rakeshkumar Yadav, et al.
The Science of The Total Environment (2021) Vol. 807, pp. 151038-151038
Open Access | Times Cited: 40
Facing the wrath of enigmatic mutations: a review on the emergence of severe acute respiratory syndrome coronavirus 2 variants amid coronavirus disease‐19 pandemic
Jatin Chadha, Lavanya Khullar, Nidhi Mittal
Environmental Microbiology (2021) Vol. 24, Iss. 6, pp. 2615-2629
Open Access | Times Cited: 35
Monoclonal antibodies for the treatment of COVID-19 patients: An umbrella to overcome the storm?
Simone Mornese Pinna, Tommaso Lupia, Silvia Scabini, et al.
International Immunopharmacology (2021) Vol. 101, pp. 108200-108200
Open Access | Times Cited: 28
Prescription of Anti-Spike Monoclonal Antibodies in COVID-19 Patients with Resistant SARS-CoV-2 Variants in Italy
Daniele Focosi, Marco Tuccori
Pathogens (2022) Vol. 11, Iss. 8, pp. 823-823
Open Access | Times Cited: 21
Growth, reproduction numbers and factors affecting the spread of SARS-CoV-2 novel variants of concern in the UK from October 2020 to July 2021: a modelling analysis
Thomas Ward, Alex Glaser, Alexander Johnsen, et al.
BMJ Open (2021) Vol. 11, Iss. 11, pp. e056636-e056636
Open Access | Times Cited: 24
Comparative mutational analysis of SARS-CoV-2 isolates from Pakistan and structural-functional implications using computational modelling and simulation approaches
Abdullah Shah, Saira Rehmat, Iqra Aslam, et al.
Computers in Biology and Medicine (2021) Vol. 141, pp. 105170-105170
Open Access | Times Cited: 24
Thiol drugs decrease SARS-CoV-2 lung injuryin vivoand disrupt SARS-CoV-2 spike complex binding to ACE2in vitro
Kritika Khanna, Wilfred W. Raymond, Jing Jin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 24
Model-driven mitigation measures for reopening schools during the COVID-19 pandemic
Ryan Seamus McGee, Julian R. Homburger, Hannah Williams, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 22
First nosocomial cluster of COVID-19 due to the Delta variant in a major acute care hospital in Singapore: investigations and outbreak response
W.P. Lim, Glorijoy Shi En Tan, Htet Lin Htun, et al.
Journal of Hospital Infection (2021) Vol. 122, pp. 27-34
Open Access | Times Cited: 22
The rapid adaptation of SARS-CoV-2–rise of the variants: transmission and resistance
Sandrine M. Soh, Yeong-Jun Kim, Chanwoo Kim, et al.
The Journal of Microbiology (2021) Vol. 59, Iss. 9, pp. 807-818
Open Access | Times Cited: 21
Upgrading nirmatrelvir to inhibit SARS-CoV-2 Mpro via DeepFrag and free energy calculations
Nguyễn Minh Tâm, Trung Hai Nguyen, Phạm Minh Quân, et al.
Journal of Molecular Graphics and Modelling (2023) Vol. 124, pp. 108535-108535
Open Access | Times Cited: 9
SARS-CoV-2 Viral Clearance and Evolution Varies by Extent of Immunodeficiency
Yijia Li, Manish C. Choudhary, James Regan, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 9
Anti-SARS-CoV-2 Strategies and the Potential Role of miRNA in the Assessment of COVID-19 Morbidity, Recurrence, and Therapy
Maria Narożna, Błażej Rubiś
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8663-8663
Open Access | Times Cited: 20
Increased lung cell entry of B.1.617.2 and evasion of antibodies induced by infection and BNT162b2 vaccination
Prerna Arora, Amy Kempf, Inga Nehlmeier, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 19

Scroll to top